Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation

American Journal of Pathology

Volumn 175, Issue 2, 2009, Pages 717-724

  Liu, Bowen ^a   Paranjpe, Shirish ^a   Bowen, William C ^a   Bell, Aaron W ^a   Luo, Jian Hua ^a   Yu, Yan Ping ^a   Mars, Wendy M ^a   Michalopoulos, George K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; GLYPICAN 3; MESSENGER RNA; OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; HEPATITIS C; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; LIVER CELL; LIVER CELL CULTURE; LIVER REGENERATION; LOSS OF FUNCTION MUTATION; NONHUMAN; ORGAN GROWTH; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIMPSON GOLABI BEHMEL SYNDROME; WESTERN BLOTTING;

EID: 68449084138     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081129     Document Type: Article

References (35)

1. Fransson LA: Glypicans. Int J Biochem Cell Biol 2003, 35:125-129
2. Song HH, Filmus J: The role of glypicans in mammalian development. Biochim Biophys Acta 2002, 1573:241-246
3. De Cat B, David G: Developmental roles of the glypicans. Semin Cell Dev Biol 2001, 12:117-125
4. Veugelers M, De Cat B, Ceulemans H, Bruystens AM, Coomans C, Durr J, Vermeesch J, Marynen P, David G: Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. J Biol Chem 1999, 274:26968-26977
5. Chen RL, Lander AD: Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. J Biol Chem 2001, 276:7507-7517
6. Filmus J: Glypicans in growth control and cancer. Glycobiology 2001, 11:19R-23R
7. Iglesias BV, Centeno G, Pascuccelli H, Ward F, Peters MG, Filmus J, Puricelli L, de Kier Joffe EB: Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development. Histol Histopathol 2008, 23:1333-1340
8. Nakatsura T, Kageshita T, Ito S, Wakamatsu K, Monji M, Ikuta Y, Senju S, Ono T, Nishimura Y: Identification of glypican-3 as a novel tumor marker for melanoma. Clin Cancer Res 2004, 10:6612-6621
9. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP, Ranganathan S, Michalopoulos GK: Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006, 44:1012-1024
10. Yamauchi N, Watanabe A, Hishinuma M, Ohashi K, Midorikawa Y, Morishita Y, Niki T, Shibahara J, Mori M, Makuuchi M, Hippo Y, Kodama T, Iwanari H, Aburatani H, Fukayama M: The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol 2005, 18:1591-1598
11. Filmus J, Capurro M: Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol Diagn 2004, 8:207-212
12. Farooq M, Hwang SY, Park MK, Kim JC, Kim MK, Sung YK: Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest. Mol Cell 2003, 15:356-360
13. Hughes-Benzie RM, Pilia G, Xuan JY, Hunter AG, Chen E, Golabi M, Hurst JA, Kobori J, Marymee K, Pagon RA, Punnett HH, Schelley S, Tolmie JL, Wohlferd MM, Grossman T, Schlessinger D, MacKenzie AE: Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families. Am J Med Genet 1996, 66:227-234
14. Pellegrini M, Pilia G, Pantano S, Lucchini F, Uda M, Fumi M, Cao A, Schlessinger D, Forabosco A: Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. Dev Dyn 1998, 213:431-439
15. Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum ND, Filmus J: Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol 1999, 146:255-264
16. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997, 276:60-66
17. Michalopoulos GK: Liver regeneration. J Cell Physiol 2007, 213:286-300
18. Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, Riley T, Howard TA, Michalopoulos GK: Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF: EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol 1996, 132:1133-1149
19. Higgins G, Anderson R: Experimental pathology of liver: restoration of liver of the white rat following partial surgical removal. Arch Pathol 1931, 12:186-202
20. Oren R, Takahashi S, Doss C, Levy R, Levy S: TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 1990, 10:4007-4015
21. Levy S, Todd SC, Maecker HT: CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998, 16:89-109
22. Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, Hemler ME: Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J Cell Biol 2004, 167:1231-1240
23. Cocquerel L, Kuo CC, Dubuisson J, Levy S: CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J Virol 2003, 77:10677-10683
24. Stolz DB, Mars WM, Petersen BE, Kim TH, Michalopoulos GK: Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res 1999, 59:3954-3960
25. Seglen PO: Preparation of isolated rat liver cells. Methods Cell Biol 1976, 13:29-83
26. Michalopoulos GK, Bowen WC, Zajac VF, Beer-Stolz D, Watkins S, Kostrubsky V, Strom SC: Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor. Hepatology 1999, 29:90-100
27. Tsuda H, Yamada S, Miyazono H, Morikawa K, Yoshida K, Goto F, Tamura JI, Neumann KW, Ogawa T, Sugahara K: Substrate specificity studies of Flavobacterium chondroitinase C and heparitinases towards the glycosaminoglycan-protein linkage region. Use of a sensitive analytical method developed by chromophore-labeling of linkage glycoserines using dimethylaminoazobenzenesulfonyl chloride. Eur J Biochem 1999, 262:127-133
28. Summerton J: Endo-Porter: a novel reagent for safe, effective delivery of substances into cells. Ann NY Acad Sci 2005, 1058:62-75
29. Van Criekinge W, Beyaert R: Yeast two-hybrid: state of the art. Biol Proced Online 1999, 2:1-38
30. Raiborg C, Stenmark H: Hrs and endocytic sorting of ubiquitinated membrane proteins. Cell Struct Funct 2002, 27:403-408
31. Grozdanov PN, Yovchev MI, Dabeva MD: The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells. Lab Invest 2006, 86:1272-1284
32. Filmus J, Capurro M: The role of glypican-3 in the regulation of body size and cancer. Cell Cycle 2008, 7:2787-2790
33. Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H: Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer 2003, 103:455-465
34. Capurro MI, Xiang YY, Lobe C, Filmus J: Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 2005, 65:6245-6254
35. Kleeff J, Ishiwata T, Kumbasar A, Friess H, Buchler MW, Lander AD, Korc M: The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 1998, 102:1662-1673